Objective: Excellent outcomes have been established for elective aortic root replacement (ARR). It is less clear whether extending the repair into the proximal aortic arch with hypothermic circulatory arrest increases risk. We examined the early outcomes of elective, primary ARR, with and without hemiarch replacement, in patients without previous cardiac surgery.
Methods: Over a 4-year period, 140 non-redo patients (median age, 54 years) underwent elective, primary ARR for root aneurysms; 119 patients (85%) had hemiarch replacement, and 21 (15%) had only ascending aortic replacement. Valve-sparing ARR was performed in 41 cases (29.3%) and valve-replacing ARR in 99 (70.7%). Moderate hypothermic circulatory arrest and antegrade cerebral perfusion were used in 118 (99%) hemiarch repairs.
Results: There were no operative deaths or permanent strokes. Complications included temporary renal dialysis (n ¼ 1; 4.8%), transient neurologic deficit (n ¼ 2; 9.5%), and tracheostomy (n ¼ 2; 9.5%) after ascending aortic repair and bleeding requiring reoperation (n ¼ 4; 3.4%), pericardial effusion requiring drainage (n ¼ 9; 7.6%), and tracheostomy (n ¼ 2; 1.7%) after hemiarch replacement. No stroke was observed in the hemiarch group (P ¼ .022; univariate analysis). The extent of the repair into the proximal arch did not appear to be associated with any adverse effect.
Conclusions:
In non-redo patients, elective primary ARR has excellent early outcomes, regardless of whether repair extends into the proximal arch. Additional elective hemiarch replacement with moderate hypothermic circulatory arrest and antegrade cerebral perfusion has a low risk of neurologic complications and should be performed if necessary. Long-term data are needed to compare the rates of reintervention in the aortic arch in patients with or without proximal arch replacement. (J Thorac Cardiovasc Surg 2017;153:1402-8)
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Central Message
In non-redo patients, elective primary aortic root replacement has excellent early outcomes, regardless of whether repair extends into the proximal arch.
Perspective
Excellent outcomes have been established for elective aortic root replacement. It is less clear whether extending the repair into the proximal aortic arch with hypothermic circulatory arrest increases risk. In non-redo patients, elective primary aortic root replacement has excellent early outcomes, regardless of whether repair extends into the proximal arch. Comparing reintervention rates in the aortic arch is important to determine the value of hemiarch replacement.
See Editorial Commentary page 1409.
Aortic root replacement (ARR) addresses aneurysmal pathology of the aortic root and the ascending aorta. If the aneurysm is not excised fully, distal progression of aneurysmal disease may later necessitate more extensive reoperation. [1] [2] [3] For disease extending into the proximal arch, additional hypothermic circulatory arrest (HCA)-which is required in the initial operation for performing an open distal anastomosis for hemiarch replacement-raises the risk for adverse outcomes, including death or permanent or temporary neurologic dysfunction. 4 HCA lasting 25 minutes or more has been associated with memory problems and fine motor deficits. 5 Because of these concerns, the optimal extent of proximal ascending aortic reconstruction in patients who require elective ARR for aortic root pathology is not clear. In our study, we focused on the safety of hemiarch replacement in patients with no previous cardiac surgery who were undergoing elective aortic root surgery. We have described the short-term outcomes of these patients and of patients who underwent ascending aortic replacement alone as part of their non-redo, elective, primary surgical ARR.
PATIENTS AND METHODS
Over an approximately 4-year period (January 2011-April 2015), 140 patients with simultaneous ascending aortic aneurysms without dissection underwent elective, primary aortic root operations at our institution. The patients' median age was 54 years (interquartile range [IQR] 25%-75%, 43-61 years; range, 15-81 years, with male predominance [n ¼ 111; 79.3%]). None of the patients had undergone previous cardiac surgery. Of the 140 patients, 119 underwent concomitant hemiarch replacement, and 21 patients had only their ascending aorta replaced during the aortic root procedure. Data were collected from a prospectively maintained database, and the institutional review board at Baylor College of Medicine (Houston, Tex) approved the retrospective study. Follow-up information concerning adverse events was obtained mainly from clinic visits, telephone calls, records from the offices of referring physicians, and the Social Security Death Index. It should be noted, however, that the data were not based only on the latter because of the current limitations of the Social Security Death Index.
The patients' preoperative characteristics are shown in Table 1 . Intraoperative variables are shown in Table 2 . Operative mortality was defined as death before hospital discharge or within 30 days of discharge. Postoperative stroke was defined as a new brain injury that was clinically or radiographically evident after the procedure. Permanent or persistent stroke was defined as stroke with no recovery at the time of hospital discharge. Transient stroke was defined as stroke with full recovery at hospital discharge. Renal injury in the postoperative period was defined as needing to start dialysis or a doubling of the patient's serum creatinine level. Persistent renal injury was defined as requiring hemodialysis at hospital discharge.
Because of the small number of postoperative adverse events, composite adverse outcome was defined as transient stroke, renal failure with transient hemodialysis, postoperative renal insufficiency, postoperative bleeding requiring operation, pericardial effusion requiring drainage, and tracheostomy.
The antegrade cerebral perfusion (ACP) time was defined as the period (during circulatory arrest) in which the patient was receiving ACP. The total circulatory arrest time was the time with and without ACP. The cardiopulmonary bypass (CPB) time was the period of CPB not including the ACP time or the circulatory arrest time. The myocardial ischemic time was the time from the initiation of circulatory arrest or crossclamp placement until clamp removal. When only the ascending aorta was replaced, the myocardial ischemic time was equal to the aortic crossclamp time.
Surgical Technique
In all patients, the procedure was performed via a median sternotomy with CPB. In the patients who underwent aortic root and hemiarch repair, the following cannulation sites were used for arterial inflow: innominate artery (n ¼ 104), right axillary artery (n ¼ 11), right subclavian artery via a median sternotomy (n ¼ 2), right common carotid artery (n ¼ 1), and side arm of the Dacron graft (n ¼ 1). In the patients who underwent aortic root and ascending aortic repair only, the arterial cannulation sites were the distal ascending aorta (n ¼ 9), innominate artery (n ¼ 7), right axillary artery (n ¼ 3), and femoral artery (n ¼ 2; these 2 patients had Marfan syndrome with severe pectus excavatum). The decision to proceed with hemiarch versus only ascending aortic replacement during the primary root operation was based on the following considerations: If the diameter of any section of the distal ascending aorta measured !4.5 cm or the rate of growth was more than 0.5 cm/year based on preoperative images, hemiarch operation was performed. In patients with connective tissue disorders, we concomitantly replaced the hemiarch if the diameter of any section of the distal ascending aorta was !4.0 cm.
Moderate hypothermia (lowest temperature, 23.7 C AE 2.2 C) with ACP was used for all patients who underwent proximal arch replacement but one. The open distal anastomosis was a beveled hemiarch anastomosis that undercut the inferior portion of the transverse arch completely opposite to the take-off site of the left subclavian artery or opposite to the left common carotid artery if the left subclavian artery was too far. Near-infrared spectroscopy was used for cerebral monitoring. When circulatory arrest was initiated with ACP, the flows were decreased to 1.5 mL/kg/min. Adjustment of the flows was dictated by near-infrared spectroscopy. In patients who had hemiarch repair, we performed the root dissection and, in some cases, placed the valvular sutures during the cooling phase if time allowed. We completed the root procedure during the rewarming period.
When the target temperature was achieved, the open distal anastomosis was performed with a continuous 3.0 or 4.0 polypropylene suture, followed by interrupted pledgeted sutures for reinforcement. For patients with ascending aortic repair only, the aorta was opened and tailored to an appropriate length after the crossclamp was applied. When ascending aortic repair alone was performed with the mechanical CVG, the Dacron graft attached to the conduit was used for the repair. The median size of the distal grafts used for the ascending anastomosis was 24 mm (IQR 22-26 mm). The already-mobilized right coronary button was then attached to the body of the Dacron graft (mechanical or bioprosthetic CVG) or the body of the Medtronic Freestyle root. After deairing had been achieved, the aortic crossclamp was released. The patient was weaned from CPB when the body temperature reached 36.5 C. Our technique for valve-sparing ARR has been described previously. 6 We use the Valsalva nonvalved root graft (Vascutek Ltd, Inchinnan, Renfrewshire, Scotland). To summarize, 6 subannular sutures are placed in the base of the aortic root Valsalva graft. A 4.0 polypropylene suture is placed in each valve commissure. After the root graft is cut to the appropriate length, the valve commissures and the leaflets are positioned inside the graft. The subannular sutures are tied. The valve commissures are secured near the top of the graft, and the supra-annular aortic tissue is sewn to the graft. We then continue with the attachment of the left coronary button, the graft-to-graft (root graft to ascending graft) anastomosis, and the right coronary button (Video 1). Values are median (25%-75% interquartile range) for continuous variables and n (%) for categorical variables. ARR, Aortic root replacement; CVG, composite valved graft; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; PRBC, packed red blood cells. *All concomitant cardiac procedures was defined as concomitant CABG, aortic valve annuloplasty, mitral valve repair/replacement, tricuspid valve repair, maze procedure, atrial/ventricular septal defect repair, patent foreman ovale repair. yAntegrade cerebral perfusion time in the hemiarch repair group is not included in the CPB time (this is why the median CPB time was less for the hemiarch repair group than for the group without hemiarch repair). Values are median (25%-75% interquartile range) for continuous variables and n (%) for categorical variables unless otherwise noted. NYHA, New York Heart Association; BAV, bicuspid aortic valve. *Coronary artery disease was defined as history of angina or myocardial infarction or percutaneous transluminal coronary angioplasty/stent. yPulmonary disease was defined as history of asthma or chronic obstructive pulmonary disease/emphysema/chronic bronchitis or restrictive lung disease. zCerebrovascular disease was defined as history of stroke or transient ischemic attack. xValues are mean AE standard deviation. kMeasurements of the distal ascending aorta for the hemiarch group were not taken.
Statistical Analysis
The differences in the distribution of preoperative, operative, and postoperative characteristics in the hemiarch and the no-hemiarch repair groups were tested with c 2 analysis, or the Fisher exact test when necessary, for the categorical variables. The nonparametric Wilcoxon 2-sample test was used for the continuous variables. In addition, these tests were used in a univariate analysis to examine the effect of preoperative and operative risk factors on adverse events after surgery. A multivariate logistic regression model with the stepwise variable selection option was then applied to further explore the effect of the univariately significant risk factors on adverse events (P <.1).
The following 19 preoperative and operative variables were used for this analysis: hemiarch repair, type of procedure (valve-sparing, mechanical, tissue/bioroot, or stentless tissue), age, sex, New York Heart Association class III/IV status, genetic disease, bicuspid aortic valve (BAV), hypertension, coronary artery disease, preoperative renal disease, atrial arrhythmia/heart block, pulmonary disease, cerebrovascular disease, previous distal [aortic] surgery, concomitant coronary artery bypass grafting (CABG), concomitant cardiac procedures, CPB time, cardiac ischemic time, and ACP time (only for the hemiarch procedure model). Multicollinearity was checked with regression analysis. Statistical analyses were performed with SAS version 9.1 (SAS Institute Inc, Cary, NC), and P <.05 was considered significant.
RESULTS
No 30-day or in-hospital mortality occurred. Two patients had a transient stroke; neither of them had undergone a hemiarch repair. Both strokes were ischemic and nonhemorrhagic. Table 3 shows the shortterm complications.
Composite Adverse Outcome
Because of the small number of adverse events, we grouped the following variables into a composite adverse outcome: transient stroke, renal failure with transient hemodialysis, postoperative renal insufficiency, postoperative bleeding requiring operation, pericardial effusion requiring drainage, and tracheostomy. A total of 16 patients in the hemiarch group (13.5%) and 3 patients in the ascending aortic group (14.3%) experienced a composite adverse outcome. Stroke was the only adverse event that had a greater incidence in the ascending group in the univariate analysis only (Table 3) . Multivariate analysis for all patients showed that concomitant CABG appeared to be associated with a composite adverse outcome (P ¼ .013; odds ratio, 4.19; 95% confidence interval, 1.35-13.06). (Tables 4 and 5 ). The CABG procedures were planned in advance (n ¼ 15; 83.3%) except for 3 patients. In these 3 patients (1 in the ascending aortic group who had a CVG; and 2 patients in the hemiarch group, 1 who had a valve-sparing root procedure and the other who had a stentless tissue root), CABG was a rescue strategy due to right ventricular failure. When we excluded the 3 patients with a rescue CABG from our cohort in the subgroup multivariate analysis, the cardiac ischemia time predicted the composite adverse event in the entire group (Table 5) .
Follow-up Evaluation
For all patients, the median follow-up period for any adverse event was 26 months (IQR 14.2-38.2 months). Two patients required surgical reintervention at our institution during the follow-up period. To our knowledge, no other patient required another surgical intervention during the follow-up period. One patient from the ascending aortic replacement group (4.8%) required endovascular repair of the infrarenal aorta 3 months after the index procedure. The patient was admitted 2 years later with prosthetic valve endocarditis and underwent redo homograft root replacement and proximal arch replacement for dilated hemiarch. This patient is still alive 21 months after the second procedure. The other patient who required reintervention (0.8%) had undergone hemiarch repair. This patient had Marfan syndrome and previous endovascular repair of the descending thoracic aorta for acute type III aortic dissection. This patient required extent III thoracoabdominal aortic replacement with removal of the endograft because of an enlarging false lumen.
DISCUSSION
The literature does not include enough data for extensive proximal arch repair to be recommended for patients with ARR. 7 The 2010 American College of Cardiology Foundation/American Heart Association/ American Association for Thoracic Surgery/American College of Radiology/American Stroke Association/Society of Cardiovascular Anesthesiologists/Society for Cardiac Angiography and Interventions/Society of Interventional Radiology/Society of Thoracic Surgeons/Society for Vascular Medicine guidelines for the diagnosis and management of patients with thoracic aortic disease do not specify the extent of aortic resection needed in patients who are undergoing elective ARR. 8 The current recommendations state that ''[p] atients undergoing aortic valve repair or replacement and who have an ascending aorta or aortic root of greater than 4.5 cm should be considered for concomitant repair of the aortic root or replacement of the ascending aorta (Class I, Level of Evidence: C).'' 8 In addition, the current recommendations state that ''[a]scending aneurysms larger than 4.5 to 5.0 cm require repair or tube graft replacement when aortic valve repair or replacement is the primary indication for operation. '' 8 In our study, we investigated whether extending repair into the proximal aortic arch after elective ARR increased the risk for adverse events. Malaisrie and colleagues 7 showed that the addition of hemiarch repair to aortic root surgery did not affect operative mortality and safety, nor did it add significant morbidity to the operation. In their study, propensity score matching of 133 pairs of patients undergoing hemiarch repair versus ascending aortic replacement alone showed that the 30-day mortality rate was equal in both groups (3% vs 1.5%; P ¼ .41). 7 No operative deaths were observed in our study, and this difference can potentially be explained by the fact that Malaisrie and colleagues included pairs of 21 redo sternotomy patients and that not all procedures were elective.
In our ascending aorta-only group, we noticed a tendency toward a greater rate of temporary stroke that was similar to the findings of Malaisrie and colleagues. 7 Nevertheless, no significant difference with regards to neurologic events was found between the 2 groups in either study. In our hemiarch group, the mean ACP time was 18 minutes, which is below the ''window'' of 25 minutes or more in which neurologic deficits, as well as mortality, can occur. 5, 9 This brief period of ACP could explain the absence of strokes or mortality in our group. This finding is extremely important in considering a more extended aortic repair towards the proximal arch.
Reoperation for bleeding occurred only in our hemiarch group and may have been due to dysfunction of the coagulation cascade during CPB, which is exacerbated by hypothermia during HCA. This difference was not significant when the hemiarch group was compared with the ascending aorta-only group; a similar finding was reported by Malaisrie and colleagues. 7 Hemostatic disturbances and coagulation problems have been reported with HCA use. 10 Careful hemostasis is warranted if the aortic root surgery is associated with proximal hemiarch operations.
In cases involving a BAV, there is a long-standing debate about the surgical threshold for associated aortopathy. [11] [12] [13] [14] In our series, BAV was observed more often in patients who underwent hemiarch replacement (46.2%) than in patients who had ascending aortic replacement (19.1%). According to the recent guidelines for surgery of the ascending aorta and the aortic valve, patients with BAV should undergo surgery if the diameter of the ascending aorta is greater than 5 cm. If there is a family history of aortic dissection, that threshold is lowered to 4.5 cm. 15 In our practice, when performing aortic root surgery in a patient with BAV, we replace the distal ascending aorta if its diameter is 4.0 cm or larger. This may explain why we had more patients with BAV in the hemiarch group.
The ascending aorta-only replacement group was younger than the hemiarch group because the ascending aorta-only group had more patients with genetically triggered thoracic aortic disease, who usually are relatively younger. In general, when we perform an elective root replacement in a patient with a connective tissue disorder, we are aggressive in replacing the proximal arch if the ascending aorta is dilated more than 4.0 cm or if there is a family history of aneurysms or dissections. Although the age difference between our 2 groups was significantly different, both groups were young and expected to respond in a similar way clinically.
With respect to the composite adverse outcome, the need for concomitant CABG, whether it was a planned or a bailout procedure, appeared to be a risk factor for adverse events in the hemiarch group. Further sensitivity analysis, which included only the planned CABG procedures, revealed that the cardiac ischemia time was associated with the composite adverse outcome in the entire group. Silva and colleagues 16 reported that a prolonged CPB time was an independent predictor of major complications in patients undergoing primary and redo aortic root procedures. In addition, the need for CABG is one of the risk factors associated with in-hospital mortality in patients undergoing aortic root operations. 16, 17 We agree with others 16, 17 that concomitant CABG during elective, non-redo aortic root operations are associated with increased morbidity. Patients who require concomitant CABG are considered a high-risk group. 18, 19 In a series reported by Byrne and colleagues, 19 the operative mortality in patients with planned CABG (18 of 87 patients; 21%) versus the mortality in patients with no need for CABG plus those who needed a CABG bailout (3 of 282 patients; 1%) was significant. Presumed misalignment of the coronary button (right or left) during implantation results in left or right ventricular failure, which necessitates concomitant CABG. In our series, 3 CABG procedures were done as part of a rescue strategy; when they were excluded from the analysis, however, the planned concomitant CABG procedures continued to predict morbidity for the hemiarch group.
Furthermore, aggressive resection of the entire diseased aortic segment may minimize the need for future reoperation. 18 Although our study focused on the effect of the surgical intervention on short-term clinical outcomes, 2 patients (1 in the ascending group and 1 in the hemiarch group) underwent subsequent surgery. With regard to the patient in the hemiarch group who had Marfan syndrome, the distal aortic intervention was expected and planned. However, firm conclusions are difficult to draw because of the small number of patients.
The main limitations of our study are its retrospective and observational nature and the small overall sample size. Because of the small number of patients who underwent only ascending aortic repair, the 2 groups were not compared; for the same reason, propensity matching score analysis was not performed. In addition, the true value of performing a hemiarch replacement can be determined only by comparing long-term rates of reintervention in the aortic arch between the 2 groups; therefore, we reported only early outcomes in this study. Nevertheless, ours is one of the few studies to focus on the safety of proximal aortic arch repair in patients with no previous cardiac surgery who are undergoing elective aortic root surgery. To avoid potential future aortic enlargement, we initially will approach non-redo, elective, primary aortic root operations by performing relatively aggressive aortic resection for root aneurysms that extend into the distal aorta.
CONCLUSIONS
In conclusion, the additional ACP time required for performing a hemiarch replacement in patients undergoing elective ARR usually is brief and not associated with mortality or serious neurologic events. Concomitant CABG can increase morbidity in patients who are undergoing elective primary ARR regardless of additional proximal arch replacement. Correct placement of the coronary buttons (right or left) to avoid misalignmentwhich can lead to left or right ventricular failure-is important. Hemiarch repair did not play a significant role with regard to any adverse events, but these results should be interpreted cautiously because of the small number of patients. Hemiarch repair should be considered when needed in patients undergoing an elective, primary root operation. To firmly draw conclusions, we need longer follow-up observation to evaluate the rate of reoperation involving the transverse arch in patients who undergo only ascending aortic replacement with aortic root surgery. We and others have shown that including a beveled hemiarch in patients who are undergoing root replacement electively has minimal associated risk. Current guidelines do not address this issue. Our findings should be confirmed in a larger, multi-institutional patient series.
